- Presentations
- 3
- Markets
- 1
Sular is a brand of Nisoldipine marketed by Covis Pharma, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Nisoldipine
- Brand owner
- Covis Pharma
- Registered in
- United States
- Strengths and forms
- 17 mg extended-release tablet, 34 mg extended-release tablet, 8.5 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Sular 17 mg extended-release tabletOral | Covis Pharma | US FDA | Available on request |
| Sular 34 mg extended-release tabletOral | Covis Pharma | US FDA | Available on request |
| Sular 8.5 mg extended-release tabletOral | Covis Pharma | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Sular
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.